United Therapeutics Corporation
UTHR | NASDAQ
$493.10
-$1.53 (-0.31%)
At close: Sep 21, 2026, 4:00 PM ET
$492.77
-$0.33 (-0.07%)
Pre-market:
Sep 22, 2026, 5:41 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 16.17 | 13.34 | 10.45 | 17.40 | 20.38 | 13.03 |
PEG Ratio | 1.16 | 0.52 | 0.33 | 0.34 | -2.26 | -0.02 |
PS Ratio | 6.78 | 5.54 | 4.42 | 6.53 | 5.76 | 4.52 |
PB Ratio | 3.04 | 2.47 | 1.72 | 2.64 | 2.45 | 1.98 |
P/FCF Ratio | 20.74 | 14.76 | 13.77 | 19.06 | 20.32 | 9.63 |
P/OCF Ratio | 13.83 | 12.02 | 10.52 | 15.77 | 16.22 | 8.88 |
OCF/S Ratio | 49.05 | 46.12 | 42.02 | 41.45 | 35.49 | 50.95 |
Debt / Equity Ratio | 0.01 | 0.05 | 0.12 | 0.17 | 0.20 | 0.24 |
Quick Ratio | 6.28 | 5.03 | 4.28 | 9.55 | 7.30 | 6.44 |
Current Ratio | 6.60 | 5.25 | 4.41 | 9.85 | 7.61 | 6.70 |
Asset Turnover | 0.40 | 0.39 | 0.32 | 0.32 | 0.33 | 0.32 |
Interest Coverage | 77.81 | 32.10 | 19.98 | 30.24 | 29.89 | 25.26 |
Return on Equity | 18.81% | 18.55% | 16.45% | 15.16% | 12.02% | 15.16% |
Return on Assets | 16.94% | 16.23% | 13.74% | 12.03% | 9.20% | 11.15% |
Return on Invested Capital | 16.13% | 15.44% | 13.54% | 13.15% | 9.16% | 11.14% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 87.92% | 89.24% | 88.94% | 92.42% | 92.73% | 92.71% |
Net Profit Margin | 41.94% | 41.53% | 42.31% | 37.56% | 28.23% | 34.71% |
Pretax Profit Margin | 53.85% | 53.49% | 54.75% | 49.09% | 35.24% | 43.07% |
Operating Profit Margin | 47.67% | 47.86% | 50.91% | 50.60% | 32.98% | 40.02% |
FCF Margin | 32.70% | 37.55% | 32.12% | 34.28% | 28.32% | 46.95% |
EBITDA Margin | 57.15% | 57.50% | 59.58% | 53.73% | 43.71% | 43.57% |
Add to Watchlist
Select watchlists to add or remove UTHR